About Holly K. Miller, DO

Dr. Holly Miller joined Phoenix Children's Hospital in 2015. Her areas of interest include transplants for patients with primary immune deficiency disorders, management of primary immune deficiencies, primary immune dysregulation disorders, bone marrow failure syndromes and cytopenias. She has authored multiple peer-reviewed manuscripts and abstracts and is currently participating in several multicenter NIH funded studies. Noting the lack of comprehensive care provided to patients with immune deficiencies and immune dysregulation disorders, she cofounded the Comprehensive Immunohematology Clinic in 2016. In the community, Dr. Miller cofounded Phoenix Children's Hospital annual Locks for Gold event in 2017, where hair donations are collected to provide hair replacement systems to any child with a medical reason for hair loss free of charge. Dr. Miller is committed to providing excellent and compassionate patient care in the field of pediatric bone marrow transplant and pediatric hematology/oncology. She offers the most up-to-date diagnostic and treatment options, and she strives to partner with other care providers to provide the most comprehensive care possible.

Medical School / Education

Lake Erie College of Osteopathic Medicine, Erie, PA


Henry Ford Medical Center, Detroit, MI


Detroit Medical Center/Children's Hospital of Michigan, Detroit, MI


University of Michigan, Ann Arbor, MI

Academic Affiliations

Instructor in Medicine, Department of Medicine, Mayo Clinic Arizona

Clinical Assistant Professor, Department of Child Health, University of Arizona College of Medicine

Assistant Clinical Professor in the Department of Pediatrics, Creighton University School of Medicine

Professional Affiliations

American Society of Bone Marrow Transplant

Arizona Chapter of the American Academy of Pediatrics

Primary Immune Deficiency Treatment Consortium (PIDTC)

North American Immuno-Hematology Clinical, Educations and Research (NICER) Consortium

Marsh RA. Leiding JW. Logan BR, Griffith LM, Arnold D, Haddad E, Falcone EL, Yin A, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu L, Oshrine BR, Cuvelier G, Thakar M, Chen K, Teira P, Shenoy S, Rhelen R, Forbes L, Chellapandian D, Davila Saldana B, Shah A, Weinacht K, Joshi A, Boulad F, Quigg T, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowen MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. Journal of Clinical Immunology. Published online 2019 Aug 2.

Zhao J, Beebe K, Magee K, Salzberg D, Stahlecker J, Miller HK, Adams RH, Lipskind S, Walsh A, Mirea L, Ngwube A. Adolescent male fertility following reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in non-malignant disorders. Pediatric Transplantation. Published online 2019 May 23.

Zhou X, O'Dwyer DN, Xia M, Miller HK, Chan PR, Trulik K, Chadwick MM, Hoffman TC, Bulte C, Bloye K, Sekerak K, Wilke CA, Patel SJ, Yokoyama WM, Murray S, Yanik GA, Moore BB. First onset herpesviral infection and lung injury in allogeneic hematopoietic cell transplanation. American Journal of Respiratory and Critical Care Medicine. Published online February 11, 2019.

Hess, J, Su L, Nizzi F, Beebe K, Magee K, Salzberg D, Stahlecker J, Miller HK, Adams RH, Ngwube A. Successful Treatment of Severe Refractory Autoimmune Hemolytic Anemia Following Hematopietic Stem Cell Transplant with Abatacept. Transfusion. 2018 Sep; 58(9):2122-2127.

Miller HK, Hanley P, Lang H, Lazarski C, Williams E, McCormack S, Roesch L, Albihani S, Dean M, Hoq F, Adams RH, Bollard C, Keller MD. Antiviral T Cells for Adenovirus in the Pretransplant Period: a Bridge Therapy for Severe Combined Immunodeficiency. Biology of Blood and Marrow Transplantation. 2018 Sep;24(9):1944-1946.

Beebe K, Magee K, McNulty A, Stahlecker J, Salzberg D, Miller H, Mirea L, Adams R, Ngwube A. Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2018 Feb;65(2).

Miller HK, Braun T, Stillwell T, Harris A, Choi S, Connelly J, Couriel D, Goldstein S, Kitko C, Magenau J, Pawarode A, Reddy P, Riwes M, Yanik G, Levine J. Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 2017 Mar;23(3):522-528.

Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H, Magenau J, Weisdorf DJ, Ho VT, Bolanos-Meade J, Alousi AM, Ferrara JL for the Blood and Marrow Transplant Clinical Trials Network. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicenter study. The Lancet Hematology. 2015 Jan;2(1):e21-9.


Phoenix Children's Hospital - Thomas Campus

1919 E. Thomas Rd.
Phoenix, AZ 85016

Get Directions